全科医学科辅助用药注射用灯盏花素住院病例使用分析  

Analysis of breviscapine for injection used in patients as an adjuvant drug in general medicine department

作　　者：崔晨玲 孙祥瑞[1] 汪庆飞[1] CUI Chen-ling;SUN Xiang-rui;WANG Qing-fei(Department of Pharmacy,The Second Affiliated Hospital of Bengbu Medical College,Bengbu 233000,China)

机构地区：[1]蚌埠医学院第二附属医院药剂科,安徽蚌埠233000

出　　处：《中国处方药》2022年第6期28-29,共2页Journal of China Prescription Drug

基　　金：蚌埠医学院自然科学基金面上项目(BYKY18132)。

摘　　要：目的 分析全科医学科住院患者使用辅助类活血化瘀药物注射用灯盏花素合理性情况,探讨辅助用药类中药注射剂临床合理使用。方法抽取106例2019年注射用灯盏花素全科医学科住院患者病历进行回顾分析。结果 病历点评发现,69例(65.09%)存在不合理用药现象,其中12例(11.32%)超说明书用药,37例(34.91%)缺乏中医诊断证型,2例(1.89%)有禁忌证,14例(13.21%)联合用药可能存在配伍禁忌。结论 辅助用药监控下的不合理用药现象依旧严重,很大程度上影响了患者的用药安全,辅助药联用较多,超说明书用药现象明显。需加强使用监管及干预,促进辅助用药的安全、有效应用。Objective To analyze the rationality of breviscapine for injection of adjuvant drugs for promoting blood circulation and removing blood stasis in inpatients of general medicine department of our hospital,and to explore the rational clinical use of adjuvant traditional Chinese medicine injections.Methods 106 inpatients with breviscapine for injection in 2019 were selected for retrospective analysis.Results In the review of medical records,there were 69(65.09%) cases of irrational drug use,including 12(11.32%) cases of off-label drug use,37(34.91%) cases of lack of TCM diagnostic syndrome,1(0.94%) case of contraindications,and 14(13.21%) cases of possible incompatibility.Conclusion Irrational drug use is still serious in our hospital under the supervision of adjunctive drug use,which largely affects the medication safety of patients.There are many adjunctive drug combinations and obvious off-label drug use.Supervision and intervention should be strengthened to promote the safe and effective use of adjuvant drugs.

关 键 词：灯盏花素 辅助用药 合理用药 

分 类 号：R288[医药卫生—中药学]